Leap Therapeutics Revenue and Competitors

Boston, MA USA

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Leap Therapeutics's estimated annual revenue is currently $8.5M per year.(i)
  • Leap Therapeutics's estimated revenue per employee is $155,000

Employee Data

  • Leap Therapeutics has 55 Employees.(i)
  • Leap Therapeutics grew their employee count by 49% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5.2M67-45%$107.3MN/A
#2
$0.3M20%N/AN/A
#3
$5.1M336%N/AN/A
#4
$11.9M77-37%$312.8MN/A
#5
$0.9M60%N/AN/A
#6
$235M300-5%$340.9MN/A
#7
$45.9M237-7%$7.6MN/A
#8
$3.9M5035%N/AN/A
#9
$5.4M353%N/AN/A
#10
$1.6M100%N/AN/A
Add Company

What Is Leap Therapeutics?

Leap Therapeutics (NASDAQ: LPTX) is a clinical-stage biopharmaceutical company acquiring and developing novel therapeutics at the leading edge of cancer research. For more information about Leap Therapeutics, visit http://www.leaptx.com or our public filings with the SEC that are available via EDGAR at http://www.sec.gov or via http://www.investors.leaptx.com.

keywords:N/A

N/A

Total Funding

55

Number of Employees

$8.5M

Revenue (est)

49%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$6.7M5531%$153M
#2
$4.3M55-68%$377.5M
#3
N/A55400%N/A
#4
$15M5617%N/A
#5
$11.1M5622%N/A